Director, Clinical OperationsAnthony J. Good, PhD
Leveraging over 25 years of experience in Clinical Development, Anthony is responsible for leading Clinical Operations in Australia for Pathios Therapeutics. Renowned for his scientific acumen and strategic leadership, Anthony has guided global clinical development programs across a diverse range of therapeutic areas, including Immuno-oncology, Immunology, Cardiovascular, Central Nervous System, Infectious Diseases, Metabolic and Endocrine, Allergy and Respiratory, and Sexual Health.
Throughout his career, Dr. Good has held pivotal roles in both academic and industrial settings, contributing significantly to the advancement of pharmaceutical science. Prior to his current position, Anthony served as Snr VP Clinical Research, Imugene Ltd, where he demonstrated his proficiency in guiding early-stage drug development programs from inception to successful FDA IND approvals and through phase 1 and 2 development.
Dr. Good’s commitment to excellence is underscored by his track record in leading clinical teams and study staff to ensure the seamless implementation of clinical studies in alignment with development plans. His strategic leadership and interactions with opinion leaders and regulatory agencies have been instrumental in the successful execution of global clinical programs on time and within budget.
A passionate advocate for translating novel science into transformative medicines, Anthony’s contributions to the pharmaceutical industry have been significant and far-reaching. He holds a PhD in Neuroscience and BSc (Hons) in Psychology, both awarded by the University of New South Wales. Anthony’s dedication to advancing healthcare through innovative clinical development makes him a valued leader in the field.